Cargando…
Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota
Dengzhan Shengmai (DZSM), a traditional Chinese medicine formulation, has been administered extensively to elderly individuals with cognitive impairment (CI). However, the underlying mechanisms by which Dengzhan Shengmai improves cognitive impairment remains unknown. This study aimed to elucidate th...
Autores principales: | Hou, Jing-Yi, Xu, He, Cao, Guang-Zhao, Tian, Liang-Liang, Wang, Li-Han, Zhu, Nai-Qiang, Zhang, Jing-Jing, Yang, Hong-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123283/ https://www.ncbi.nlm.nih.gov/pubmed/37101548 http://dx.doi.org/10.3389/fphar.2023.1175970 |
Ejemplares similares
-
Mechanism of Action of Dengzhan Shengmai in Regulating Stroke from an Inflammatory Perspective: A Preliminary Analysis of Network Pharmacology
por: Yan, Yiqi, et al.
Publicado: (2021) -
Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
por: Pan, Jianheng, et al.
Publicado: (2021) -
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020) -
Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats
por: You, Yu, et al.
Publicado: (2020) -
Ferulic Acid Ameliorates Atherosclerotic Injury by Modulating Gut Microbiota and Lipid Metabolism
por: Gu, Yuyan, et al.
Publicado: (2021)